Integra Adds ACell’s Regenerative Tech As It Dumps Extremity Orthopedics
Executive Summary
Integra will pay up to $400m for ACell to expand its wound management and soft-tissue repair product line. The deal is part of a larger restructuring plan that includes selling its orthopedics business.
You may also be interested in...
JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.
JPM 2021: EY Says Pandemic Leaves Medtech With $500Bn In M&A Firepower
EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.
New Trial Shows BENEFIT Of J&J/Auris’ Monarch Bronchoscopy Platform
New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: